Cited by 502Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Neuron loss in APP transgenic mice

Calhoun, Michael E., Wiederhold, Karl-Heinz, Abramowski, Dorothee, Phinney, Amie L., Probst, Alphonse, Sturchler-Pierrat, Christine, Staufenbiel, Matthias, Sommer, Bernd, Jucker, Mathias·1998·Nature

DOI 10.1038/27351

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1038/27351

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 12

Sturchler-Pierrat, C.et al. Proc. Natl Acad. Sci. USA 94, 13287–13292 (1997).
West, M. J., Coleman, P. D., Flood, D. G. & Troncoso, J. C. Lancet 344, 769–772 (1994).
Regeur, L., Jensen, G. B., Pakkenberg, H., Evans, S. M. & Pakkenberg, B. Neurobiol. Aging 15, 347–352 (1994).
Gomez-Isla, T.et al. J. Neurosci. 16, 4491–4500 (1996).
Pakkenberg, B. & Gundersen, H. J. J. Comp. Neurol. 384, 312–320 (1997).
Calhoun, M. E. et al. (in the press).
Hsiao, K.et al. Science 274, 99–102 (1996).
Irizarry, M. C.et al. J. Neurosci. 17, 7053–7059 (1997).
Irizarry, M. C., McNamara, M., Fedorchak, K., Hsiao, K. & Hyman, B. T. J. Neuropathol. Exp. Neurol. 56, 965–973 (1997).
Mattson, M. P.et al. Neuron 10, 243–254 (1993).
Jucker, M. & Ingram, D. K. Behav. Brain Res. 85, 1–26 (1997).
West, M. J. Neurobiol. Aging 14, 275–285 (1993).

Sorted by citations

Items 101–200 of 501

Cholinergic Changes in the APP23 Transgenic Mouse Model of Cerebral Amyloidosis
Boncristiano, S., Calhoun, M. E., Kelly, P. H., Pfeifer, M., Bondolfi, L., Stalder, M., Phinney, A. L., Abramowski, D., Sturchler-Pierrat, C., Enz, A., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03234.2002 · Cited by 160
Self-citation
The molecular and cellular basis of copper dysregulation and its relationship with human pathologies
Maung, M. T., Carlson, A., Olea‐Flores, M., Elkhadragy, L., Schachtschneider, K. M., Navarro‐Tito, N., & Padilla‐Benavides, T. (2021) · The FASEB Journal · doi:10.1096/fj.202100273rr · Cited by 158
Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 155
Primary Phagocytosis of Neurons by Inflamed Microglia: Potential Roles in Neurodegeneration
Neher, J. J., Neniškytė, U., & Brown, G. C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00027 · Cited by 157
Transgenic mouse models of Alzheimer's disease: phenotype and application.
(2003) · PubMed · doi:10.1097/01.fbp.0000088420.18414.ff · Cited by 147
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
Katsouri, L., Lim, Y. M., Blondrath, K., Eleftheriadou, I., Lombardero, L., Birch, A. M., Mirzaei, N., Irvine, E. E., Mazarakis, N. D., & Sastre, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606171113 · Cited by 146
Alzheimer's Disease and the Amyloid β Protein
Small, D. H., & McLean, C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730443.x · Cited by 146
An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Pang, K., Jiang, R., Zhang, W., Yang, Z., Li, L., Shimozawa, M., Tambaro, S., Mayer, J., Zhang, B., Li, M., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00582-x · Cited by 147
System Xc−and Apolipoprotein E Expressed by Microglia Have Opposite Effects on the Neurotoxicity of Amyloid-β Peptide 1–40
Qin, S., Colin, C., Hinners, I., Gervais, A., Cheret, C., & Mallat, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5186-05.2006 · Cited by 135
Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult
Rosenblum, W. I. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.085 · Cited by 142
Extracellular amyloid formation and associated pathology in neural grafts
Meyer‐Luehmann, M., Stalder, M., Herzig, M. C., Kaeser, S. A., Kohler, E., Pfeifer, M., Boncristiano, S., Mathews, P. M., Mercken, M. H., Abramowski, D., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1022 · Cited by 137
Self-citation
Parenchymal and vascular Aβ‐deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease
Thal, D. R., Griffin, W. S. T., & Braak, H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00411.x · Cited by 134
Animal models of Alzheimer disease: historical pitfalls and a path forward
Cavanaugh, S. E. (2014) · ALTEX · doi:10.14573/altex.1310071 · Cited by 132
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic
Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 133
Induction of Brain-Derived Neurotrophic Factor in Plaque-Associated Glial Cells of Aged APP23 Transgenic Mice
Burbach, G. J., Hellweg, R., Haas, C. A., Del Turco, D., Deicke, U., Abramowski, D., Jucker, M., Staufenbiel, M., & Deller, T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5599-03.2004 · Cited by 132
Self-citation
The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders
Perry, G. L., Sayre, L. M., Atwood, C., Castellani, R. J., Cash, A., Rottkamp, C. A., & Smith, M. A. (2002) · CNS Drugs · doi:10.2165/00023210-200216050-00006 · Cited by 130
Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation
Lalonde, R., Dumont, M., Staufenbiel, M., Sturchler, C., & Strazielle, C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03476-5 · Cited by 135
Self-citation
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136
Does my mouse have Alzheimer's disease?
Dodart, J., Mathis, C., Bales, K. R., & Paul, S. M. (2002) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2002.10302.x · Cited by 126
Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease
Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C., Hosokawa, M., & McGeer, P. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.016 · Cited by 126
Changes in extracellular space size and geometry in APP23 transgenic mice: A model of Alzheimer's disease
Syková, E., Voříšek, I., Antonova, T., Mazel, T., Meyer-Luehmann, M., Jucker, M., Hájek, M., Or, M., & Bureš, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408235102 · Cited by 121
Self-citation
Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation
Pierrot, N., Santos, S. F., Feyt, C., Morel, M., Brion, J., & Octave, J. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606015200 · Cited by 121
Recent rodent models for Alzheimer’s disease: clinical implications and basic research
Braidy, N., Muñoz, P., Palacios, A. G., Castellano‐González, G., Inestrosa, N. C., Chung, R. S., Sachdev, P. S., & Guillemin, G. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0731-5 · Cited by 126
Mouse Models of Alzheimer's Disease: Insight into Treatment
German, D. C., & Eisch, A. J. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.5.353 · Cited by 114
High-resolution mapping of brain vasculature and its impairment in the hippocampus of Alzheimer's disease mice
Zhang, X., Yin, X., Zhang, J., Li, A., Gong, H., Luo, Q., Zhang, H., Gao, Z., & Jiang, H. (2019) · National Science Review · doi:10.1093/nsr/nwz124 · Cited by 117
Oxidative stress mechanisms and potential therapeutics in Alzheimer disease
Moreira, P. I., Siedlak, S. L., Aliev, G., Zhu, X., Cash, A., Smith, M. A., & Perry, G. L. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0242-8 · Cited by 119
Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen
Lalonde, R., Dumont, M., Staufenbiel, M., & Strazielle, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.06.020 · Cited by 118
Self-citation
Regulation of tau phosphorylation and protection against β‐amyloid‐induced neurodegeneration by lithium. Possible implications for Alzheimer's disease
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Ávila, J., Bogónez, E., & Díaz‐Nido, J. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01150.x · Cited by 116
Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures
Egaña, J. T., Zambrano, C. A., Núñez, M. T., González-Billault, C. E., & Maccioni, R. B. (2003) · BioMetals · doi:10.1023/a:1020727218493 · Cited by 114
No hippocampal neuron or synaptic bouton loss in learning-impaired aged β-Amyloid precursor protein-null mice
Phinney, A. L., Calhoun, M. E., Wolfer, D. P., Lipp, H., Zheng, H., & Jucker, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00645-9 · Cited by 120
Self-citation
Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
Eriksen, J. L., & Janus, C. G. (2007) · Behavior Genetics · doi:10.1007/s10519-006-9118-z · Cited by 146
Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease
Faure, A., Verret, L., Bozon, B., El Tannir El Tayara, N., Ly, M., Kober, F., Dhenain, M., Rampon, C., & Delatour, B. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.009 · Cited by 112
Alzheimer's in 3D culture: Challenges and perspectives
D'Avanzo, C., Aronson, J., Kim, Y. H., Choi, S. H., Tanzi, R. E., & Kim, D. Y. (2015) · BioEssays · doi:10.1002/bies.201500063 · Cited by 111
Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease
Wirths, O., & Bayer, T. A. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/723782 · Cited by 117
Amyloid-β Deposition Is Associated with Decreased Hippocampal Glucose Metabolism and Spatial Memory Impairment in APP/PS1 Mice
Sadowski, M., Pankiewicz, J. E., Scholtzova, H., Ji, Y., Quartermain, D., Jensen, C. H., Duff, K., Nixon, R. A., Gruen, R. J., & Wısnıewskı, T. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.418 · Cited by 108
Recent advances on neuronal caspases in development and neurodegeneration
Marks, N., & Berg, M. J. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00061-3 · Cited by 109
Genes, models and Alzheimer's disease
Chapman, P. F., Falinska, A. M., Knevett, S. G., & Ramsay, M. F. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02285-5 · Cited by 108
Behavioral Disturbances without Amyloid Deposits in Mice Overexpressing Human Amyloid Precursor Protein with Flemish (A692G) or Dutch (E693Q) Mutation
Kumar‐Singh, S., Dewachter, I., Moechars, D., Lübke, U., Jonghe, C. D., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P. P., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0272 · Cited by 106
Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials
Wilcock, D. M., & Colton, C. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15404 · Cited by 107
Strain Background Influences Neurotoxicity and Behavioral Abnormalities in Mice Expressing the Tetracycline Transactivator
Han, H. J., Allen, C. C., Buchovecky, C. M., Yetman, M. J., Born, H. A., Marin, M. A., Rodgers, S. P., Song, B. J., Lu, H.-C., Justice, M. J., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0893-12.2012 · Cited by 105
Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment
King, D. L., & Arendash, G. W. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03294-2 · Cited by 105
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Animal models of dementia and cognitive dysfunction
Neha, N., Sodhi, R. K., Jaggi, A. S., & Singh, N. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.05.017 · Cited by 104
Transgenic mouse models of Alzheimer's disease: How useful have they been for therapeutic development?
Duff, K. (2004) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/3.1.47 · Cited by 98
Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain
Wengenack, T. M., Whelan, S. L., Curran, G. L., Duff, K., & Poduslo, J. F. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00388-2 · Cited by 97
An Update of Animal Models of Alzheimer Disease with a Reevaluation of Plaque Depositions
Lee, J. E., & Han, P. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.2.84 · Cited by 101
Alzheimer's disease and the amyloid cascade hypothesis: ten years on
Sommer, B. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00126-6 · Cited by 98
Self-citation
The cell cycle–apoptosis connection revisited in the adult brain
Bauer, Š., & Patterson, P. H. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505072 · Cited by 99
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown, D. R. (2005) · PubMed · Cited by 97
Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease
Wirths, O., Breyhan, H., Schäfer, S., Roth, C., & Bayer, T. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.004 · Cited by 97
Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice
Schafer, M. J., Alldred, M. J., Lee, S. H., Calhoun, M. E., Petkova, E., Mathews, P. M., & Ginsberg, S. D. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.043 · Cited by 97
Self-citation
Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
Philipson, O., Lord, A., Gumucio, A., O'Callaghan, P. W., Lannfelt, L., & Nilsson, L. N. G. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07564.x · Cited by 101
Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes
Gómez-Isla, T., & Frosch, M. P. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00642-9 · Cited by 96
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 97
Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice
Zhang, M., Zheng, C.-Y., Zou, M., Zhu, J.-W., Zhang, Y., Wang, J., Liu, C., Li, Q., Xiao, Z., Li, S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.009 · Cited by 94
Selecting a Mouse Model of Alzheimer’s Disease
Chin, J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0_13 · Cited by 98
Transgenic Mouse Models of Alzheimer's Disease
Bornemann, K. D., & Staufenbiel, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06653.x · Cited by 89
Self-citation
Prions, prionoids and pathogenic proteins in Alzheimer disease
Ashe, K. H., & Aguzzi, A. (2013) · Prion · doi:10.4161/pri.23061 · Cited by 89
Acetylcholinesterase-Positive Fiber Deafferentation and Cell Shrinkage in the Septohippocampal Pathway of Aged Amyloid Precursor Protein London Mutant Transgenic Mice
Bronfman, F. C., Moechars, D., & LEUVEN, F. V. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 86
Neurogenesis and Alterations of Neural Stem Cells in Mouse Models of Cerebral Amyloidosis
Ermini, F., Grathwohl, S. A., Radde, R., Yamaguchi, M., Staufenbiel, M., Palmer, T. D., & Jucker, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.060520 · Cited by 92
Self-citation
Transgenic mouse models of Alzheimer's disease
Hock, B. J., & Lamb, B. T. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02449-0 · Cited by 85
Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition
Abramowski, D., Wiederhold, K.-H., Furrer, U., Jaton, A.-L., Neuenschwander, A., Runser, M.-J., Danner, S., Reichwald, J., Ammaturo, D., Staab, D., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.140327 · Cited by 89
Self-citation
Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease
Richardson, J. C., Kendal, C., Anderson, R., Priest, F., Gower, E., Soden, P. E., Gray, R., Topps, S., Howlett, D. R., Lavender, D., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00389-0 · Cited by 85
Distribution, progression and chemical composition of cortical amyloid-β deposits in aged rhesus monkeys: similarities to the human
Sani, S., Traul, D., Klink, A., Niaraki, N., Gonzalo-Ruiz, A., Wu, C.-K., & Geula, C. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0626-5 · Cited by 83
Longitudinal Amyloid Imaging in Mouse Brain with 11C-PIB: Comparison of APP23, Tg2576, and APPswe-PS1dE9 Mouse Models of Alzheimer Disease
Snellman, A., Lopez‐Picon, F. R., Rokka, J., Salmona, M., Forloni, G., Scheinin, M., Solin, O. H., Rinne, J. O., & Haaparanta‐Solin, M. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110163 · Cited by 83
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
Tenner, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00301-3 · Cited by 81
Murine models of Alzheimer's disease and their use in developing immunotherapies
Wısnıewskı, T., & Sigurdsson, E. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.05.004 · Cited by 84
Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders
Takao, K., Yamasaki, N., & Miyakawa, T. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.02.009 · Cited by 80
Age-Dependent Impairment of Somatosensory Response in the Amyloid Precursor Protein 23 Transgenic Mouse Model of Alzheimer's Disease
Mueggler, T., Kindler, D., Rausch, M., Staufenbiel, M., & Rudin, M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08231.2003 · Cited by 82
Self-citation
The value of incomplete mouse models of Alzheimer’s disease
Radde, R., Duma, C. C., Goedert, M., & Jucker, M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0704-y · Cited by 83
Self-citation
Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances
Vloeberghs, E., Dam, D. V., Engelborghs, S., Nagels, G., Staufenbiel, M., & Deyn, P. P. D. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03755.x · Cited by 80
Self-citation
Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications
Sabbagh, J. J., Kinney, J. W., & Cummings, J. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.027 · Cited by 80
Developing mouse models of aging: a consideration of strain differences in age-related behavioral and neural parameters☆
Ingram, D. K., & Jucker, M. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00033-0 · Cited by 80
Self-citation
Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
Eisele, Y. S., & Duyckaerts, C. J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1516-y · Cited by 82
Islet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 79
Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches
Soto, C. A. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050371 · Cited by 78
In Vivo Multiphoton Imaging of a Transgenic Mouse Model of Alzheimer Disease Reveals Marked Thioflavine-S-Associated Alterations in Neurite Trajectories
D'Amore, J. D., Kajdasz, S. T., McLellan, M. E., Bacskai, B. J., Stern, E. A., & Hyman, B. T. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.137 · Cited by 89
Early onset amyloid lesions lead to severe neuritic abnormalities and local, but not global neuron loss in APPPS1 transgenic mice
Rupp, N. J., Wegenast‐Braun, B. M., Radde, R., Calhoun, M. E., & Jucker, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.014 · Cited by 77
Self-citation
Indirubin-3'-monoxime rescues spatial memory deficits and attenuates β-amyloid-associated neuropathology in a mouse model of Alzheimer's disease
Ding, Y., Qiao, A., & Fan, G.-H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.022 · Cited by 75
Experimental models of Alzheimer's disease for deciphering the pathogenesis and therapeutic screening (Review)
Li, X., Bao, X., & Wang, R. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2428 · Cited by 78
Amyloid precursor protein increases cortical neuron size in transgenic mice
Oh, E. S., Savonenko, A. V., King, J. F., Fangmark Tucker, S. M., Rudow, G. L., Xu, G., Borchelt, D. R., & Troncoso, J. C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.024 · Cited by 75
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
“A reduction in the CA1 neuron number of 14% has been demonstrated; however, in this study, both hemi- and homozygous mice with an age of 14 to 18 months were included, which complicates interpretation of the data [41].”
Background
Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
Poon, C. H., Wang, Y., Fung, M., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1026 · Cited by 76
Leptin gene therapy attenuates neuronal damages evoked by amyloid-β and rescues memory deficits in APP/PS1 mice
Pérez‐González, R., Alvira-Botero, X., Avendaño, O. F. R., Antequera, D., Garzón, M., Martín-Moreno, A. M., Brera, B., CEBALLOS, M. L. D., & Carro, E. (2014) · Gene Therapy · doi:10.1038/gt.2013.85 · Cited by 72
Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice
Roder, S., Danober, L., Pozza, M. F., Lingenhoehl, K., Wiederhold, K., & Olpe, H. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00381-6 · Cited by 71
Self-citation
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
Molecular and cellular gerontology Serpiano, Switzerland, September 18–22, 1999
Brack, C., Lithgow, G. J., Osiewacz, H., & Toussaint, O. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.1929 · Cited by 73
Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP/PS1 mice
O’Neil, J. N., Mouton, P. R., Tizabi, Y., Ottinger, M. A., Lei, D.-L., Ingram, D. K., & Manaye, K. F. (2007) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2007.05.008 · Cited by 68
Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau
Castellani, R. J., Lee, H., Perry, G. L., & Smith, M. A. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750602100213 · Cited by 72
Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing β-amyloid precursor protein (APP) with the Swedish double mutation (APP23)
Diez, M., Danner, S., Frey, P., Sommer, B., Staufenbiel, M., Wiederhold, K., & Hökfelt, T. G. M. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.003 · Cited by 70
Self-citation
Comparison of unbiased estimation of neuronal number in the rat hippocampus with different staining methods
Zhu, Y., Liu, F., Zou, X., & Torbey, M. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.07.022 · Cited by 69
Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice
Boncristiano, S., Calhoun, M. E., Howard, V., Bondolfi, L., Kaeser, S. A., Wiederhold, K.-H., Staufenbiel, M., & Jucker, M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.010 · Cited by 68
Self-citation
Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
Vyas, Y., Montgomery, J. M., & Cheyne, J. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00266 · Cited by 66
Progress toward valid transgenic mouse models for Alzheimer’s disease
Guénette, S. Y., & Tanzi, R. E. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00042-1 · Cited by 67
Amyloid-Beta Peptide Is Toxic to Neurons In Vivo via Indirect Mechanisms
Walsh, D. T., Montero, R., Bresciani, L. G., Jen, A., Leclercq, P. D., Saunders, D., EL-Amir, A. N., Gbadamoshi, L., Gentleman, S. M., & Jen, L. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0485 · Cited by 70
Elimination of the Class A Scavenger Receptor Does Not Affect Amyloid Plaque Formation or Neurodegeneration in Transgenic Mice Expressing Human Amyloid Protein Precursors
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65489-2 · Cited by 49
Nonviral Aβ DNA vaccine therapy against Alzheimer’s disease: Long-term effects and safety
Okura, Y., Miyakoshi, A., Kohyama, K., Park, I.-K., Staufenbiel, M., & Matsumoto, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600966103 · Cited by 66
Self-citation
Transgenic animals relevant to Alzheimer’s disease
Seabrook, G. R., & Rosahl, T. W. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00170-1 · Cited by 63

Authors: Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M.
Affiliations: University of Basel (CH)
Novartis (Switzerland) (CH)
ORCID: Calhoun, Michael E.
Sommer, Bernd
Jucker, Mathias
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1998-10
Volume: 395
Issue: 6704
Pages: 755-756
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/27351
OpenAlex: W1572812739
Cited by: 502
References: 2
Citations by year: 2026: 1 · 2025: 9 · 2024: 9 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 9 · 2019: 11 · 2018: 10 · 2017: 16 · 2016: 8 · 2015: 20 · 2014: 15 · 2013: 19 · 2012: 21
FWCI: 17.41
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, amyloid plaques, amyloid precursor protein, APP transgenic mice, neuronal cell death, neurodegeneration, familial Alzheimer's disease
MeSH terms: Alzheimer Disease, Animals, Humans, Mice, Transgenic, Mutation, Neurons, Amyloid beta-Protein Precursor, Cell Death, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuron loss in APP transgenic mice

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks